# Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

> **NCT00700895** · PHASE3 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 320 (estimated)

## Conditions studied

- Indications for Warfarin Therapy

## Interventions

- **DRUG:** Warfarin Sodium

## Key facts

- **NCT ID:** NCT00700895
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** 2016-08
- **Final completion:** 2017-08
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00700895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00700895, "Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00700895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*